Company Filing History:
Years Active: 2016-2025
Title: Innovations by Inventor Xue Zhang
Introduction
Xue Zhang, based in San Diego, California, is a celebrated inventor known for his pivotal contributions in the field of biomedical research. With a total of five patents to his name, Xue has made significant strides in developing novel antiviral therapies, particularly against human immunodeficiency virus (HIV).
Latest Patents
Two of Xue Zhang’s most recent patents stand out for their innovative approach to combating HIV. The first patent focuses on "Human immunodeficiency virus neutralizing antibodies," which provides novel anti-HIV antibodies with enhanced therapeutic properties, pharmaceutical compositions, and methods of use. The second patent, titled "Antibodies that target HIV GP120 and methods of use," reveals antibodies that bind to HIV gp120, effectively neutralizing the virus. It also outlines methods of using these antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.
Career Highlights
Throughout his career, Xue has held significant positions at leading biopharmaceutical companies. He has worked at Gilead Sciences, Inc. and Anaptysbio, Inc., where he has played a crucial role in advancing research that addresses viral infections and immunotherapy.
Collaborations
Xue Zhang has collaborated with notable coworkers, including Mini Balakrishnan and Brian A Carr. These partnerships have fostered an environment of innovation, leading to the development of transformative solutions in healthcare.
Conclusion
Xue Zhang's advancements in HIV research and his impressive portfolio of patents underscore his commitment to improving therapeutic options for patients. His work exemplifies the vital role of innovators in tackling pressing health challenges through cutting-edge science and collaboration.